Electronic Skin Market Size, Share & Trends Analysis Report By Product Type, By Component (Stretchable Circuits, Photovoltaics Systems), By Sensors (Tactile Sensors, Chemical Sensors), By Application, By Region, And Segment Forecasts, 2025 - 2030

Electronic Skin Market Size, Share & Trends Analysis Report By Product Type, By Component (Stretchable Circuits, Photovoltaics Systems), By Sensors (Tactile Sensors, Chemical Sensors), By Application, By Region, And Segment Forecasts, 2025 - 2030


Electronic Skin Market Growth & Trends

The global electronic skin market size is anticipated to reach USD 37.1 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 23.0% from 2025 to 2030. The rising number of geriatric population and continuous technological advancements are driving the market. Moreover, in the e-textile area, researchers are using 3D printing to make material that can store and harvest electricity as well as fulfill fashion demand. These players are focusing on the miniaturization of products and continuous technological development. The major players in the industry are investing in research and development activities and are continuously innovating their products.

For Instance, Xenoma is developing an e-skin that monitors fitness and health with printed circuit fabrics. Many researchers are addressing electronic skin due to its relevant application in robotics and biomedical system. Thin soft sensors that stick onto the skin are transforming healthcare. The data they collect is fed into a machine-learning algorithm to monitor spot abnormalities and tract treatment. These sensors can track biological and physiological signals such as breathing, motion, temperature, and cardiac rhythms.

Many players in the industry are commercializing soft biosensors system that measures clinical data continuously. These electronic skins can monitor electric pulses from the heart and are more effective than the intermittent hospital's check-ups. The increasing number of diabetes patients and rising awareness about self-monitoring are also increasing the demands. According to the International Diabetes Federation, the number of people with diabetes is expected to reach 700 million by 2045.

Electronic Skin Market Report Highlights
  • North America captured the largest share in 2024 owing to the factors such as the presence of a large number of market players and high adoption rate
  • By product type, electronic patches dominated the market owing to rising awareness about self-monitoring in healthcare
  • By component, stretchable circuits dominated the market owing to its high use in various application of healthcare and e-textile
  • Based on sensors, the tactile sensors segment is expected to witness the fastest CAGR over the forecast period owing to the high adoption rate in the field of robotics, machine learning, and physiological monitoring
  • Based on application, the drug delivery system segment is expected to grow at the fastest pace owing to increasing diabetes patients
  • Key players are focusing on the miniaturization of products and continuous technological development
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Nutrients
1.2.3. End Use
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Nutrients’ outlook
2.2.3. End use outlook
2.3. Competitive Insights
Chapter 3. U.S. Intravenous Solutions Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of chronic diseases
3.2.1.2. Aging population
3.2.1.3. Advancements in medical technology
3.2.2. Market restraint analysis
3.2.2.1. High costs associated with IV therapy due to shortages
3.2.2.2. Risk of complications
3.3. U.S. Intravenous Solutions Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Pipeline Analysis
Chapter 4. U.S. Intravenous Solutions Market: Product Estimates & Trend Analysis
4.1. Global U.S. Intravenous Solutions Market: Product Dashboard
4.2. Global U.S. Intravenous Solutions Market: Product Movement Analysis
4.3. Global U.S. Intravenous Solutions Market by Product, Revenue
4.4. Total Parenteral Nutrition (TPN)
4.4.1. Total parenteral nutrition (TPN) market estimates and forecasts 2018 to 2030 (USD Billion)
4.5. Peripheral Parenteral Nutrition (PPN)
4.5.1. Peripheral parenteral nutrition (PPN) market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 5. U.S. Intravenous Solutions Market: Nutrients Estimates & Trend Analysis
5.1. Global U.S. Intravenous Solutions Market: Nutrients Dashboard
5.2. Global U.S. Intravenous Solutions Market: Nutrients Movement Analysis
5.3. Global U.S. Intravenous Solutions Market by Nutrients, Revenue
5.4. Carbohydrates
5.4.1. Carbohydrates market estimates and forecasts 2018 to 2030 (USD Billion)
5.5. Single Dose Amino Acids
5.5.1. Single dose amino acids market estimates and forecasts 2018 to 2030 (USD Billion)
5.6. Vitamins And Minerals
5.6.1. Vitamins and minerals market estimates and forecasts 2018 to 2030 (USD Billion)
5.7. Parenteral Lipid Emulsion
5.7.1. Parenteral lipid emulsion market estimates and forecasts 2018 to 2030 (USD Billion)
5.8. Others
5.8.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 6. U.S. Intravenous Solutions Market: End Use Estimates & Trend Analysis
6.1. Global U.S. Intravenous Solutions Market: End Use Dashboard
6.2. Global U.S. Intravenous Solutions Market: End Use Movement Analysis
6.3. Global U.S. Intravenous Solutions Market by End Use, Revenue
6.4. Home
6.4.1. Home market estimates and forecasts 2018 to 2030 (USD Billion)
6.5. Hospitals
6.5.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Billion)
6.6. Infusion Center
6.6.1. Infusion center market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Manufacturers
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2024
7.4. Company Profiles
7.4.1. Fresenius Kabi AG
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Pfizer Inc.
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. Baxter
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
7.4.4. B. Braun Melsungen AG
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. JW Life Science
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. ICU Medical, Inc.
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. Grifols USA, LLC
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. Amphastar Pharmaceuticals, Inc.
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiatives
7.4.9. Athenex, Inc.
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Product benchmarking
7.4.9.4. Strategic initiatives
7.4.10. Rockwell Medical, Inc.
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Product benchmarking
7.4.10.4. Strategic initiatives
7.4.11. Exela Pharma Sciences, LLC
7.4.11.1. Company overview
7.4.11.2. Financial performance
7.4.11.3. Product benchmarking
7.4.11.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings